Mellon Medical is unveiling a patented ground breaking global innovation in suturing technology. The company has developed a platform technology for suturing with a single hand. The Switch®, a disposable precision-suturing instrument, enables surgeons to suture tubular and layered structures about twice as fast as the conventional technique. The technology is expected to reduce the risk of complications, resulting in improved patient outcome and a reduction of costs. Mellon expects market introduction of the Switch® – which has been successfully tested by a large number of experienced vascular surgeons – in 2017, once final development and CE certification process have been completed.
The Switch® can be operated by lightly pinching the double-action buttons with thumb and index finger of one hand. The other hand is free to present the tissue to be sutured. This technique greatly improves the precision and efficiency of the suturing process, as surgeons no longer need to switch the needle between instruments and focus on getting control over the needle.
In the Switch®, the needle is always secured in one of the two jaws. The predictable linear path followed by the straight needle causes less motion friction, reducing the likelihood of damage to the vessel wall and resulting in a high quality connection.
Source: Mellon Medical
The Switch® can be operated by lightly pinching the double-action buttons with thumb and index finger of one hand. The other hand is free to present the tissue to be sutured. This technique greatly improves the precision and efficiency of the suturing process, as surgeons no longer need to switch the needle between instruments and focus on getting control over the needle.
In the Switch®, the needle is always secured in one of the two jaws. The predictable linear path followed by the straight needle causes less motion friction, reducing the likelihood of damage to the vessel wall and resulting in a high quality connection.
Source: Mellon Medical
No comments:
Post a Comment